Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly …
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Day One Biopharmaceuticals, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Day One Biopharmaceuticals, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Day One Biopharmaceuticals, Inc..